Journals / Ahi Evran Tıp Dergisi / 2026 / Volume: 8 Issue: 1

The Prevalence and Distribution of High Risk Human Papilloma Virus İnfection From Turkish Women with Normal Cytology: A Single Center Study

Normal Servikal Sitolojili Kadınlarda Yüksek Riskli Human Papillomavirus Sıklığı Ve Tip 16/18 Dağılımı: Tek Merkez Çalışma

Hatice Şeneldir(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-1429-6776
Beyda Gümüştaş(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-1102-4337
Gülsüm Günhan(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-7709-5501
Feride Ebrar Kıllı(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0003-3408-9595
Berivan Ozan(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0001-5929-2157
İsmail Canbaş(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-1687-7646
Deryagül Sevindi(İSTANBUL MEDENİYET ÜNİVERSİTESİ, TIP FAKÜLTESİ)0000-0002-7135-4717
Pages
—
Publication Date
2024-04-29
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, this rate was found to be 11.73% independent of age groups and was found to be consistent with the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study was to investigate the prevalence and age distribution of high risk human papilloma virus (hrHPV) infection from Turkish women with normal cytology.
📊
Key Findings & Data:Materials and Methods: Our study population consisted of 4212 women with normal cytology and adequate hrHPV molecular testing.
💡
Conclusion & Impact:In this study, this rate was found to be 11.73% independent of age groups and was found to be consistent with the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:hrHPV · type 16/18 · cervix

Abstract

Purpose: The aim of this study was to investigate the prevalence and age distribution of high risk human papilloma virus (hrHPV) infection from Turkish women with normal cytology. Materials and Methods: Our study population consisted of 4212 women with normal cytology and adequate hrHPV molecular testing. The cases were divided into 5 groups according to their age ranges as 21-25 years old, 25-29 years old, 30-44 years old, 45-54, and 55-65 years old. Groups were compared with hrHPV positivity and type 16/18 positivity. Results: Hr HPV was detected in 494 (11.73 %) of 4212 cases. The positivity of hr HPV were 31.97% in group 1 (21-24 years), 18.34% in group 2 (25-29 years), 11.29% in group 3 (30-44 years), 8.73% in group 4 (45-54 years), and 10.18% in group 5 (55-65 years) . There was statistically significant difference in the rates of hrHPV between group 1 and the other groups (p <0.05). There was statistically significant difference in the rates of hrHPV of group 2 and the other groups (p <0.05) . There was statistically significant difference in the rates of type 16 between groups 1 and the other groups (p <0.05). Conclusion: According to meta-analysis studies, hrHPV positivity has been reported in approximately 6.6% of women with normal cytology. This rate varies between 1.4% and 25.6%, being more frequent in societies with low-middle socioeconomic status. In this study, this rate was found to be 11.73% independent of age groups and was found to be consistent with the literature.

Özet

Amaç: Serviks kanseri, kadınlarda en yaygın görülen kanser türlerinden biridir. Serviks kanserinin Human Papilloma virüs (HPV) ile ilişkisi kanıtlanmış olup hastaların tamamına yakınında HPV DNA varlığı gösterilmiştir. Çalışmadaki amacımız; normal servikal sitolojili kadınlarda yaşlara göre yüksek riskli HPV (hrHPV) sıklığını ve tip 16/18 dağılımını araştırmak ve diğer çalışmalarla karşılaştırmasını yapmaktır. Araçlar ve Yöntem: Çalışmamızda İstanbul Medeniyet Üniversitesi Prof. Dr. Süleyman Yalçın Şehir Hastanesi Tıbbi Patoloji Anabilim Dalı’nda 01.10.2018-01.10.2020 tarihleri arasında, servikal sitolojisi malignite açısından negatif ve hrHPV DNA incelemesi yapılmış 4212 servikal sitolojik materyal retrospektif olarak değerlendirildi. Olgular, yaşlarına göre 21-24 yaş, 25-29 yaş, 30-44 yaş, 45-54 ve 55-65 yaş olmak üzere 5 gruba ayrıldı. Gruplar hrHPV pozitifliği ve tip 16/18 dağılımı açısından analiz edildi. Bulgular: Toplam 4212 olgunun 494’ünde (%11.73) hrHPV pozitifliği saptandı. Grup 1 (21-24 yaş), grup 2 (25-29 yaş), grup 3 (30-44 yaş), grup 4 (45-54 yaş) ve grup 5 (55-65 yaş) hrHPV pozitiflik oranı sırası ile %31.97, %16.83, %18.34, %11.29, %8.73 ve % 10.18 olarak bulundu. HrHPV pozitifliği açısından Grup 1 ve 2 ile diğer gruplar arasında istatistiksel olarak anlamlı farklılık bulunmaktadır (p<0.05). HPV tip 16 pozitifliği açısından Grup 1 ve diğer gruplar arasında istatistiksel olarak anlamlı farklılık bulunmaktadır (p<0.05), grup 2, 3, 4 ve 5 arasında anlamlı bir farklılık bulunmamaktadır (p>0.05). Sonuç: Meta analiz çalışmalarına göre; normal sitolojili kadınlarda yaklaşık %6.6 oranında hrHPV pozitifliği bildirilmiştir. Bu oran düşük-orta sosyoekonomik düzeydeki toplumlarda daha sık olmak üzere %1.4 ile %25.6 arasında değişmektedir. Bu çalışmada da yaş gruplarından bağımsız bu oran %11.73 olarak saptanmış literatür ile uyumlu olarak bulunmuştur.

🔖

Cite This Article

Şeneldir, H., Gümüştaş, B., Günhan, G., Kıllı, F. E., Ozan, B., Canbaş, İ., Sevindi, D. (2024). The Prevalence and Distribution of High Risk Human Papilloma Virus İnfection From Turkish Women with Normal Cytology: A Single Center Study. Ahi Evran Tıp Dergisi, Volume: 8 Issue: 1. https://doi.org/10.46332/aemj.1232937

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020:GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3): 209-249.
  2. Arbyn M, Weiderpass E, Bruni L, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health. 2020;8(2):e191-e203.
  3. Perkins RB, Guido RS, Castle PE, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis. 2020;24(2):102-131.
  4. Inal MM, Köse S, Yildirim Y, et al. The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. International journal of gynecological cancer: official journal of the International Gy-necological Cancer Society. 2007;17(6):1266-1270.
  5. Akcali S, Goker A, Ecemis T, Kandiloglu A R, Sanlidag T. Human papilloma virus frequency and genotype distribu-tion in a Turkish population. Asian Pacific journal of cancer prevention: APJCP. 2013;14(1): 503-506.
  6. Tezcan S, Ozgur D, Ulger M, et al. Human papillomavirus genotype distribution and E6/E7 oncogene expression in Turkish women with cervical cytological findings. Asian Pacific journal of cancer prevention: APJCP. 2014;15(9):3997-4003.
  7. Şahiner F, Kubar A, Yapar M, Şener K, Dede M, Gümral R. Detection of major HPVs by a new multiplex real-time PCR assay using type-specific primers. J. Microbiol. Methods. 2014;97:44-50.
  8. Yuce K, Pinar A, Salman MC, et al. Detection and genotyping of cervical HPV with simultaneous cervical cytology in Turkish women: a hospital-based study. Arch. Gynecol. Obstet. 2012;286(1):203-208.
  9. Bruni L, Albero G, Serrano B, et al. ICO/IARC HPV ve Kanser Bilgi Merkezi. Dünyada İnsan Papilloma Virüsü ve İlgili Hastalıklar. Özet raporu; 2023.
  10. Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, et al. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. Int J Cancer. 2018;142(9):1952-1958.
  11. De Sanjosé S, Diaz M, Castellsagué X, et al. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a metaanalysis. The Lancet. Infect. Dis. 2007;7(7):453-459.
  12. Wang Z, Liu T, Wang Y, et al. Risk of cervical lesions in high-risk HPV positive women with normal cytology: a retrospective single center study in China. Infect Agent Cancer.2020;15:34.
  13. Dursun P, Ayhan A, Mutlu L, et al. HPV types in Turkey: multicenter hospital based evaluation of 6388 patients in Turkish gynecologic oncology group centers. Turk Patoloji Derg. 2013;29(3):210-216.
  14. Akyar I, Aydın Ö, Yakıcıer MC, Kocagöz T, İnce Ü, Ünsal İ. Human papillomavirus prevalence and type in liquid-based cervical samples from Turkish women in a selected risk group. Turk J Med Sci. 2013;43(6):963-970.
  15. Eren F, Erenus M, Bas E, Ahiskali R, Yoldemir T. Prevalence of HPV infection by cytologic diagnosis and HPV DNA extraction and prevalence of the HPV genotypes detected in urban Turkish women. Int J Gynaecol Obstet. 2010;109(3):235-238.
  16. Erdoğdu İH. Moleküler Hpv Uygulanan Olgularda Hpv Sonuçları ile Patolojik Materyallerin Karşılaştırılması. Dicle Tıp Derg. 2019;46(1): 167-172.
  17. Argyri, E., Papaspyridakos, S., Tsimplaki, E. et al. A cross sectional study of HPV type prevalence according to age and cytology. BMC Infect Dis. 2013;13(1): 1-8.